24HourWire
News from all angles
MedPage Today
Center
GLP-1s and Hepatic Events; 'Shame, Taboo, Hygiene'; Treating Late-Onset IBD
(MedPage Today) -- Among U.S. adults with diabetes and steatotic liver disease in the All of Us cohort, new use of a GLP-1 receptor agonist was linked with a 38% to 42% lower risk of hepatic events o…